Showing 1 - 10 results of 10 for search 'Carmen Peña-Bautista', query time: 0.04s Refine Results
  1. 1
    Assessment of Lipid Peroxidation in Alzheimer’s Disease Differential Diagnosis and Prognosis

    Assessment of Lipid Peroxidation in Alzheimer’s Disease Differential Diagnosis and Prognosis by Laura Ferré-González, Carmen Peña-Bautista, Miguel Baquero, Consuelo Cháfer-Pericás

    Published 2022-03-01
    Get full text
    Article
  2. 2
    Isoprostanoids Levels in Cerebrospinal Fluid Do Not Reflect Alzheimer’s Disease

    Isoprostanoids Levels in Cerebrospinal Fluid Do Not Reflect Alzheimer’s Disease by Carmen Peña-Bautista, Miguel Baquero, Marina López-Nogueroles, Máximo Vento, David Hervás, Consuelo Cháfer-Pericás

    Published 2020-05-01
    Get full text
    Article
  3. 3
    Epigenomics and Lipidomics Integration in Alzheimer Disease: Pathways Involved in Early Stages

    Epigenomics and Lipidomics Integration in Alzheimer Disease: Pathways Involved in Early Stages by Carmen Peña-Bautista, Lourdes Álvarez-Sánchez, Antonio José Cañada-Martínez, Miguel Baquero, Consuelo Cháfer-Pericás

    Published 2021-12-01
    Get full text
    Article
  4. 4
    Discordant Amyloid Status Diagnosis in Alzheimer’s Disease

    Discordant Amyloid Status Diagnosis in Alzheimer’s Disease by Lorena García-Vallés, Carmen Peña-Bautista, Lourdes Álvarez-Sánchez, Inés Ferrer-Cairols, Miguel Baquero, Consuelo Cháfer-Pericás

    Published 2022-11-01
    Get full text
    Article
  5. 5
    Assessment of Screening Approach in Early and Differential Alzheimer’s Disease Diagnosis

    Assessment of Screening Approach in Early and Differential Alzheimer’s Disease Diagnosis by Laura Ferré-González, Carmen Peña-Bautista, Lourdes Álvarez-Sánchez, Inés Ferrer-Cairols, Miguel Baquero, Consuelo Cháfer-Pericás

    Published 2021-10-01
    Get full text
    Article
  6. 6
    Angiotensin II Receptor Blockers Reduce Tau/Aß42 Ratio: A Cerebrospinal Fluid Biomarkers’ Case-Control Study

    Angiotensin II Receptor Blockers Reduce Tau/Aß42 Ratio: A Cerebrospinal Fluid Biomarkers’ Case-Control Study by Gemma García-Lluch, Carmen Peña-Bautista, Lucrecia Moreno Royo, Miguel Baquero, Antonio José Cañada-Martínez, Consuelo Cháfer-Pericás

    Published 2023-03-01
    Get full text
    Article
  7. 7
    Clinical Utility of Plasma Lipid Peroxidation Biomarkers in Alzheimer’s Disease Differential Diagnosis

    Clinical Utility of Plasma Lipid Peroxidation Biomarkers in Alzheimer’s Disease Differential Diagnosis by Carmen Peña-Bautista, Lourdes Álvarez, Thierry Durand, Claire Vigor, Ana Cuevas, Miguel Baquero, Máximo Vento, David Hervás, Consuelo Cháfer-Pericás

    Published 2020-07-01
    Get full text
    Article
  8. 8
    Misfolded alpha-synuclein detection by RT-QuIC in dementia with lewy bodies: a systematic review and meta-analysis

    Misfolded alpha-synuclein detection by RT-QuIC in dementia with lewy bodies: a systematic review and meta-analysis by Carmen Peña-Bautista, Rakesh Kumar, Rakesh Kumar, Miguel Baquero, Miguel Baquero, Jan Johansson, Consuelo Cháfer-Pericás, Axel Abelein, Daniel Ferreira

    Published 2023-05-01
    Get full text
    Article
  9. 9
    Plasma microRNAs as potential biomarkers in early Alzheimer disease expression

    Plasma microRNAs as potential biomarkers in early Alzheimer disease expression by Carmen Peña-Bautista, Adrián Tarazona-Sánchez, Aitana Braza-Boils, Angel Balaguer, Laura Ferré-González, Antonio J. Cañada-Martínez, Miguel Baquero, Consuelo Cháfer-Pericás

    Published 2022-09-01
    Get full text
    Article
  10. 10
    Lipid Peroxidation Assessment in Preclinical Alzheimer Disease Diagnosis

    Lipid Peroxidation Assessment in Preclinical Alzheimer Disease Diagnosis by Carmen Peña-Bautista, Lourdes Álvarez-Sánchez, Inés Ferrer, Marina López-Nogueroles, Antonio José Cañada-Martínez, Camille Oger, Jean-Marie Galano, Thierry Durand, Miguel Baquero, Consuelo Cháfer-Pericás

    Published 2021-06-01
    Get full text
    Article

Search Tools: